Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Gossamer Bio, Inc. (GOSS) had Stock-Based Compensation of $2.40M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$9.89M |
|
$-36.64M |
|
-- |
|
$9.89M |
|
$46.70M |
|
$-36.81M |
|
$0.17M |
|
$-36.64M |
|
$-36.64M |
|
$-36.64M |
|
$-36.64M |
|
$-36.64M |
|
$-36.64M |
|
$-36.81M |
|
$-38.89M |
|
226.82M |
|
226.82M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$275.48M |
|
$0.03M |
|
$5.11M |
|
$280.59M |
|
$48.22M |
|
$197.76M |
|
$238.62M |
|
$286.84M |
|
$-6.25M |
|
$-6.25M |
|
$-6.25M |
|
227.22M |
|
| Cash Flow Statement Financials | |
$-39.72M |
|
$22.06M |
|
$0.50M |
|
$46.07M |
|
$29.02M |
|
$-17.05M |
|
|
Stock-Based Compensation |
$2.40M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.71 |
|
-- |
|
-- |
|
1.03 |
|
-31.64 |
|
100.00% |
|
-372.23% |
|
-372.23% |
|
-- |
|
-370.49% |
|
-370.49% |
|
$-39.75M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
1.50 |
|
59.91 |
|
586.19% |
|
586.21% |
|
-13.06% |
|
-19.13% |
|
$-0.03 |
|
$-0.18 |
|
$-0.18 |
|